Exclusive benefit: Australia approves use of DSM’s 3-FL for the first time 20-Feb-2023 By Tingmin Koe Australia’s Therapeutic Goods Administration (TGA) has approved for the first time the use of 3-fucosyllactose (3-FL) as a complementary medicine ingredient in listed medicines, such as dietary supplements.
